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FSHD is an autosomal dominant myopathy characterized by
progressive atrophy of skeletal muscles. FSHD region gene 1 (FRG1)
is a leading candidate gene for FSHD pathology. Overexpressing FRG1
in mouse skeletal muscle or Xenopus tadpoles results in an FSHD-like
phenotype. We analyzed expression of endogenous C. elegans FRG1
(Zk1010.3) and found that early in development FRG1 is a nuclear
protein, in adult animals the endogenous FRG1 protein was primarily
cytoplasmic, indicating a developmental regulation of subcellular
localization and potentially multiple roles for FRG1 in muscle
development. Misexpression of FRG1 by either RNAi knockdown or
transgenic overexpression disrupts the normal growth rate. Over-
expression of FRG1 also affected adult animals, which displayed
disrupted ventral body wall muscles and shifted FRG1 subcellular
localization predominantly to the nucleus through all developmental
stages yet appeared to enhance cytoplasmic actin bundling. Our
results support a disease model that overexpression of FRG1 leads to
FSHD pathology.
doi:10.1016/j.ydbio.2009.05.559
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Sprouty1 (Spry1) encodes a protein that modulates RAS/MAPK
pathway activity downstream of receptor tyrosine kinase activation.
Spry1 null mice develop cardiac hypertrophy. A detailed expression
analysis has revealed that Spry1 is expressed in the epicardium, the
outermost layer of the heart, on embryonic day (E) 12.5, and is not
detected in cardiomyocytes. At E14.5, Spry1 expression can be found
in cardiac fibroblasts (CF) and the smooth muscle cell (SMC) of the
coronary vessels. Spry1 expression in these non-myocyte populations
is maintained during adulthood. Since Sprouty genes are known to
function intracellularly, these data indicate that Spry1 function is
required in the epicardium and/or its derivatives to prevent
hypertrophy of cardiomyocytes. We suggest that the cardiac
hypertrophy phenotype in Spry1 null mice is due to a defect in CFs
that causes an increase in the amount of extracellular matrix (ECM)
in the myocardium and/or a change in ECM composition. In support
of this hypothesis, we have data suggesting that there is excess
collagen deposition in Spry1 null hearts resulting from an upregula-
tion of the SOX9 and SLUG in CFs. Preliminary data, using a
conditional gene targeting strategy that specifically inactivates Spry1
in CFs and SMCs, indicate that cardiac hypertrophy is caused by the
lack of Spry1 in these cell populations.
doi:10.1016/j.ydbio.2009.05.560
Program/Abstract # 419
Control of embryonic stem cell proliferation and migration can be
controlled in vivo by pharmacological modulation of endogenous
ion channels
Douglas J. Blackistona, Michael Levina,b
aCenter for Regenerative and Dev. Biol., Forsyth Institute, Boston, MA,
USA
bDepartment of Biol., Tufts Univ., Medford, MA, USA
Voltage gradients across cells, and the underlying ion transporters
giving rise to membrane potential, are important regulators of a
variety of developmental processes including cell specification,
differentiation, and migration. These processes in turn regulate many
morphogenetic events including embryonic development and regen-
eration. Here, we report that altering the membrane potential of
Xenopus laevis embryos during neurulation through molecular or
pharmacological treatments leads to a striking hyper-pigmentation in
embryos. This hyper-pigmentation is characterized by 1) a significant
increase in number of melanocytes, 2) dendritic and abnormal
melanocyte morphology, and 3) invasiveness of pigment cells to
areas normally devoid of pigmentation including neural tissues and
internal organs. We find these effects to be non-cell autonomous and
can be induced through disruptions of either potassium or chloride
ion gradients, suggesting a general membrane potential mechanism
as opposed to specific ion channel signaling. These data demonstrate
the importance of membrane potential during development as an
important regulator of cell division and behavior, and show the
potential for modulation of embryonic stem cell development, in
vivo, using small molecule drugs to tune membrane potential.
Progress in this field may yield profound insight into cancer and
regenerative medicine.
doi:10.1016/j.ydbio.2009.05.561
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